hypoglycaemic drugs

hypoglycaemic drugs

Drugs used in the treatment of Type II (maturity-onset) DIABETES. The term is not normally applied to INSULIN.
References in periodicals archive ?
Long acting hypoglycaemic drugs should be stopped 24 hours before surgery.
So, with this background the present study is being undertaken to see the effect of vitamin D in glycaemic control in type 2 diabetic patients on oral hypoglycaemic drugs.
Participants were to have had T2D for at least two years, be older than 25 years, and have had hyperlipidaemia and hyperglycaemia at study commencement despite treatment with statins and oral hypoglycaemic drugs for at least three months.
The study subjects comprised of total 30 males and females aged 20 - 55 years and above who are known cases of DM type II on oral hypoglycaemic drugs and non diabetic individuals, taking both the groups in equal numbers.
Limited tenders are invited for Medicines for echs polyclinics: Hypoglycaemic Drugs
Effects of Hypoglycaemic Drugs on Bone Metabolism and Fracture Risk
4] Sulfonylureas have been used in diabetes mellitus for decades and are the most widely used oral hypoglycaemic drugs.
It is comparatively free of significant side effects and unlike most other oral hypoglycaemic drugs lacks a significant risk of producing hypoglycaemia, which itself can also increase cardiovascular risk.
The 65s and over Anyone with a serious medical condition, particularly children with long term conditions of chronic respiratory disease, heart disease, renal disease and chronic liver disease, diabetes requiring insulin or oral hypoglycaemic drugs and immunosuppression.
Anyone with an underlying health condition including: Chronic respiratory disease, such as chronic obstructive pulmonary disease (COPD); Chronic heart disease; Chronic kidney disease, such as kidney failure; Chronic liver disease; Chronic neurological disease; Diabetes requiring insulin or oral hypoglycaemic drugs and immunosuppression.